Access to medicines through global health diplomacy

Vijay Kumar Chattu ^1,2,3 * , Bawa Singh ⁴ , Sanjay Pattanshetty ⁵ , Srikanth Reddy ^6,7

Cited by CrossRef: 0

1- Seretis S, Mavroudeas S, Aksu Tanık F, Benos A, Kondilis E. COVID-19 Pandemic and Vaccine Imperialism. Review of Radical Political Economics. 2024; [Crossref]

2- Chattu V, Alla S, Singh B. Political prioritization for digital health and health equity through global health diplomacy. Health Promot Perspect. 2024;14(2):89 [Crossref]

3- Ashiwaju B, Orikpete O, Alade E, Raji A, Adesanya A, Nwankwo T. Impact of Drug Price Regulation on Patient Access to Medicines: A Systematic Review. 2023;7(4):112 [Crossref]

4- Bayked E, Assfaw A, Toleha H, Zewdie S, Biset G, Ibirongbe D, Kahissay M. Willingness to pay for National Health Insurance Services and Associated Factors in Africa and Asia: a systematic review and meta-analysis. Front Public Health. 2024;12 [Crossref]

5- Weldon I, Liddell K, Rogers Van Katwyk S, Hoffman S, Minssen T, Outterson K, Palmer S, Viens A, Viñuales J. Analyzing antimicrobial resistance as a series of collective action problems. Policy Studies Journal. 2024;52(4):833 [Crossref]

6- Mendis S, Graham I. Prevention and control of cardiovascular disease in “real-world” settings: sustainable implementation of effective policies. Front Cardiovasc Med. 2024;11 [Crossref]

7- Kumar Chattu V, Pushkaran A, Narayanan P. Political Prioritization of Access to Medicines and Right to Health: Need for an Effective Global Health Governance Through Global Health Diplomacy Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry’s Role in Widening the Access Gap". Int J Health Policy Manag. 2024;13:8578 [Crossref]

8- Yadav S, Rawal G, Jeyaraman M. India’s Decision to Deny an Extension of Patent for Bedaquiline: A Public Health Imperative. 2023; [Crossref]